Risk factors for joint symptoms in the ATAC trial

被引：0
|
作者：
Sestak, I [1 ]
机构：
[1] Wolfson Inst Prevent Med, London, England
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2007年 / 106卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S108 / S108
页数：1
相关论文
共 50 条
  • [31] PERIMENSTRUAL SYMPTOMS - PREVALENCE AND RISK-FACTORS
    LOGUE, CM
    MOOS, RH
    PSYCHOSOMATIC MEDICINE, 1986, 48 (06): : 388 - 414
  • [32] PREVALENCE AND RISK FACTORS FOR INSOMNIA SYMPTOMS AND DIAGNOSES
    Roth, T.
    Kessler, R. C.
    Hajak, G.
    Coulouvrat, C.
    Walsh, J. K.
    SLEEP, 2010, 33 : A202 - A202
  • [33] Risk factors of autistic symptoms in children with ADHD
    Kroeger, Anne
    Haenig, Susann
    Seitz, Christiane
    Palmason, Haukur
    Meyer, Jobst
    Freitag, Christine M.
    EUROPEAN CHILD & ADOLESCENT PSYCHIATRY, 2011, 20 (11-12) : 561 - 570
  • [34] Postpartum urinary symptoms: prevalence and risk factors
    Pregazzi, R
    Sartore, A
    Troiano, L
    Grimaldi, E
    Bortoli, P
    Siracusano, S
    Guaschino, S
    EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2002, 103 (02): : 179 - 182
  • [35] Risk factors for early postpartum depressive symptoms
    Bloch, M
    Rotenberg, N
    Koren, D
    Klein, E
    GENERAL HOSPITAL PSYCHIATRY, 2006, 28 (01) : 3 - 8
  • [36] Awareness of lung cancer symptoms and risk factors
    Hanson, Hanna Maria
    Raag, Mait
    Adrat, Merje
    Laisaar, Tanel
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44
  • [37] Risk factors for osteoarthritis -: Understanding joint vulnerability
    Felson, DT
    CLINICAL ORTHOPAEDICS AND RELATED RESEARCH, 2004, (427) : S16 - S21
  • [38] Modifiable Risk Factors in Total Joint Arthroplasty
    Jiranek, William
    JOURNAL OF ARTHROPLASTY, 2016, 31 (08): : 1619 - 1619
  • [39] The ATAC trial: the vanguard trial for use of aromatase inhibitors in early breast cancer
    Cuzick, Jack
    EXPERT REVIEW OF ANTICANCER THERAPY, 2007, 7 (08) : 1089 - 1094
  • [40] Previous hormone-replacement therapy (HRT) and anastrozole treatment appear to be major risk factors for developing joint symptoms
    Reactions Weekly, 2008, 1226 (1) : 3 - 3
12345